AI Summary

Allan-Herndon-Dudley syndrome is a rare congenital disease of thyroid metabolism. It occurs in approximately 1 out of every 70,000 male newborns, and its effects are devastating. Since early 2025, a medication has been approved in Europe that can alleviate symptoms and extend patients' life expectancy. However, the dosage is complicated.

AI summaries can be wrong sometimes—always verify important details using the source article.